Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy

Cancer

Volumn 119, Issue 19, 2013, Pages 3436-3445

  Han, Yifang ^a   Cai, Hui ^b   Ma, Liye ^b   Ding, Yibo ^a   Tan, Xiaojie ^a   Chang, Wenjun ^a   Guan, Wei ^a   Liu, Yan ^a   Shen, Qiuxia ^a   Yu, Yongwei ^b   Zhang, Hongwei ^a   Cao, Guangwen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

chemoresistance; gastric cancer; NR4A2; prognosis; surgery

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; FLUOROURACIL; NUCLEAR RECEPTOR RELATED FACTOR 1;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CANCER; STOMACH CARCINOGENESIS; SURVIVAL PREDICTION;

CHEMORESISTANCE; GASTRIC CANCER; NR4A2; PROGNOSIS; SURGERY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM STAGING; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; POSTOPERATIVE CARE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 84884901745     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28228     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Correa P, Houghton J,. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007; 133: 659-672.
3. 2 signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology. 2011; 140: 596-607.e7.
4. Jiang X, Hiki N, Nunobe S, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012; 107: 275-279.
5. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW,. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011; 377: 31-41.
6. Oba M, Miwa K, Fujimura T, et al. A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats. Cancer. 2009; 115: 454-464.
7. Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012; 61: 812-818.
8. Han YF, Cao GW,. Role of of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers. World J Gastroenterol. 2012; 18: 6865-6873.
9. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T,. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 1997; 276: 248-250.
10. Sekiya T, Kashiwagi I, Inoue N, et al. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat Commun. 2011; 2: 269.
11. Mix KS, McMahon K, McMorrow JP, et al. Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription. Arthritis Rheum. 2012; 64: 2126-2136.
12. Holla VR, Mann JR, Shi Q, DuBois RN,. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006; 281: 2676-2682.
13. Zagani R, Hamzaoui N, Cacheux W, et al. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers. Gastroenterology. 2009; 137: 1358-1366.
14. Ke N, Claassen G, Yu DH, et al. Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res. 2004; 64: 8208-8212.
15. Chang W, Ma L, Lin L, et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer. 2009; 125: 2844-2853.
16. Lin FC, Liu YP, Lai CH, et al. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells. Oncogene. 2012; 31: 4302-4316.
17. Pradeep A, Sharma C, Sathyanarayana P, et al. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene. 2004; 23: 3689-3699.
18. Yu J, Tao Q, Cheng YY, et al. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer. 2009; 115: 49-60.
19. Barranco SC, Townsend CM Jr, Casartelli C, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983; 43: 1703-1709.
20. Akagi T, Kimoto T,. Human cell line (HGC-27) derived from the metastatic lymph node of gastric cancer. Acta Med Okayama. 1976; 30: 215-219.
21. Tan X, He S, Han Y, et al. Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients. Cancer Cell Int. 2013; 13: 20.
22. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008; 13: 272-286.
23. Cao G, Kuriyama S, Gao J, et al. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter. Gene Ther. 1999; 6: 83-90.
24. Cheng TY, Wu MS, Lin JT, et al. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer. 2012; 118: 5757-5767.
25. Higashiyama M, Ito T, Tanaka E, Shimada Y,. Prognostic significance of osteopontin expression in human gastric carcinoma. Ann Surg Oncol. 2007; 14: 3419-3427.
26. Brudvik KW, Taskén K,. Modulation of T cell immune functions by the prostaglandin E(2)-cAMP pathway in chronic inflammatory states. Br J Pharmacol. 2012; 166: 411-419.
27. Aherne CM, McMorrow J, Kane D, FitzGerald O, Mix KS, Murphy EP,. Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol. 2009; 46: 3345-3357.
28. Li X, Tai HH,. Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis. 2009; 30: 1606-1613.
29. Inamoto T, Czerniak BA, Dinney CP, Kamat AM,. Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer. 2010; 116: 340-346.
30. Shigeishi H, Higashikawa K, Hatano H, et al. PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction. Cancer Lett. 2011; 307: 227-236.
31. Terashima M, Kitada K, Ochiai A, et al. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res. 2012; 18: 5992-6000.
32. Paoletti X, Oba K, Burzykowski T, et al. GASTRIC Group. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010; 303: 1729-1737.